InvestorsHub Logo

rmzport

04/17/14 12:49 PM

#58658 RE: cabel #58655

"At one of the présentations it was said that it was very good,... is there any other objective proof that the number of cycles done by these terminally ill patients is good,...? "
Proof?...Perhaps, but none that has been made available to common share holders that I am aware of.
My fall back position here is, and has been, if Kevetrin fails in PH 1, CTIX gets kicked to the curb. No one goes to the trouble and expense of getting a company publicly listed only to fail asap.
Knowing that, Dr Menon and Leo chose to populate this "safety" trial with arguably the most health compromised among us.
Hard to imagine them finding a better way to show their high level of confidence in K.
Adding in B and P....hard not to own some of this imo